0001600620-24-000074.txt : 20240522
0001600620-24-000074.hdr.sgml : 20240522
20240522161131
ACCESSION NUMBER: 0001600620-24-000074
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240521
FILED AS OF DATE: 20240522
DATE AS OF CHANGE: 20240522
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Jayne David R.W.
CENTRAL INDEX KEY: 0001838242
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36421
FILM NUMBER: 24973353
MAIL ADDRESS:
STREET 1: #1203-4464 MARKHAM STREET
CITY: VICTORIA
STATE: A1
ZIP: BC V8Z7X8
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Aurinia Pharmaceuticals Inc.
CENTRAL INDEX KEY: 0001600620
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 981231763
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: #140, 14315 - 118 AVENUE
CITY: EDMONTON
STATE: A0
ZIP: T5L 4S6
BUSINESS PHONE: 250-744-2487
MAIL ADDRESS:
STREET 1: #140, 14315 - 118 AVENUE
CITY: EDMONTON
STATE: A0
ZIP: T5L 4S6
4
1
wk-form4_1716408679.xml
FORM 4
X0508
4
2024-05-21
0
0001600620
Aurinia Pharmaceuticals Inc.
AUPH
0001838242
Jayne David R.W.
#140, 14315 - 118 AVENUE
EDMONTON
A0
T5L 4S6
ALBERTA, CANADA
1
0
0
0
0
Common Stock
2024-05-21
4
S
0
4946
5.74
D
44364
D
Represents the number of shares automatically sold to cover tax withholding obligations in connection with the vesting of Restricted Stock Units granted on May 19, 2023.
/s/ David R.W. Jayne, M.D.
2024-05-22